From my experience and research, while TrumpRx promotes itself as a game-changer in lowering prescription medication prices, especially for diabetes drugs, it largely redirects users to existing manufacturer programs like LillyDirect and discounts similar to those found on sites like GoodRx or Mark Cuban’s Cost Plus Drugs. The key takeaway is that TrumpRx itself is not a pharmacy nor a novel discount program but rather a platform connecting patients to current cash-pay options. For many patients, this means it doesn't offer new or significantly better discounts beyond what is already available through well-known manufacturer assistance programs or coupon services. For example, the diabetes medication Zepbound (tirzepatide) featured on TrumpRx often shows prices equivalent to those on LillyDirect, the official channel for the drug distribution, and savings cards. Patients should still verify what their insurance covers and explore co-pay assistance and direct manufacturer programs, as these can sometimes offer better deals depending on individual eligibility. In practical terms, if you have insurance, your co-pay might be lower than the cash price listed on TrumpRx. It’s vital to compare all options before making a purchasing decision. Also, programs like GoodRx have been widely used by healthcare providers to help patients reduce out-of-pocket costs and they generally provide accessible, reliable coupons. Ultimately, TrumpRx might serve as a convenient centralized site to start your search for lower drug prices, but it does not replace the deeper, more personalized assistance and savings opportunities available through existing manufacturer and pharmacy programs. For managing chronic conditions requiring expensive medications, I recommend consulting with your healthcare provider or a pharmacist to navigate all savings options effectively rather than relying solely on one platform like TrumpRx.